Approximately 70% of all PAVMs occur in association with Hereditary Hemorrhagic Telangiectasia (HHT) and more than 20% of patients with HHT develop pulmonary arteriovenous malformations. Pulmonary arteriovenous malformations, usually asymptomatic, however, could present in the fourth to sixth decade of life with the development of congestive heart failure, respiratory failure with cyanosis, life threatening cerebrovascular complications including stroke and cerebral abcesess as their first manifestations. Patients with HHT are at 35% or more risk of developing these arteriovenous malformations especially if at least one of the family member have already been diagnosed with these lesions. Screening for PAVMs in asymptomatic patients with HHT is warranted and remains crucial for early detection and prevention of complications especially when a family member has already been diagnosed with these malformations. We present here a case report of a patient with pulmonary arteriovenous malformations secondary to Hereditary Hemorrhagic Telangiectasia, who was treated successfully with coil embolization.
INTRODUCTION
Pulmonary arteriovenous malformations (PAVM), also known as lung hemangiomas or pulmonary arteriovenous aneurysms are an uncommon clinical problem, which can be congenital or acquired. Approximately 70% of all PAVMs occur in association with Hereditary Hemorrhagic Telangiectasia (HHT) and more than 20% of patients with HHT develop pulmonary arteriovenous malformations. We present here a case of a 39 years old female patient with HHT and multiple pulmonary PAVMs, who was successfully treated with coil embolization.
CASE REPORT
A 39 year old Caucasian female patient with a history of HHT presented with dysnea on exertion for one and a half years. She did not have any breathing difficulty in the past but her symptoms had now progressed to the point that she was short of breath even on speaking. She denied orthopnea or paroxsysmal nocturnal dysnea and stated that lying supine made her feel much better as opposed to sitting up or standing. Her dysnea was classified as NYHA class III at the time of presentation. She had been diagnosed with HHT several years ago, following repeated nosebleeds.
Her physical examination revealed multiple telangiectasias on her abdomen, medial aspect of her right arm and anterior thighs. Her cardiovascular and respiratory system examinations were within normal limits. However, she was found to have significant orthodeoxia as her oxygen saturation dropped from 89% in supine position to 83% on sitting up after 2-3 minutes. Her chest radiograph revealed enlargement of the pulmonary artery trunk and the right main pulmonary artery along with a 1-1/2 X 1-1/2 cm nodule in the right lower lobe. A comparison of her most recent arterial blood gas to the one she had had 12 years ago showed worsening of the PO2 from 67 mm Hg to 61 mmHg on room air. Likewise, during the same time period, her Dlco dropped from 89% to 70 % predicted. Spirometry revealed normal lung volumes.
In view of the platypnea-orthodeoxia and family history of PAVMs associated with HHT, a provisional diagnosis of PAVMs associated with HHT was made.
Further evaluation with a CT angiogram revealed multiple PAVMs with feeding arteries and draining veins identified for each lesion. In the left lung, three peripheral AVMs and one central AVM were identified. In the right lower lobe,
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two peripheral AVMs and one large central AVM were identified. Coil Embolization of each identifiable PAVM was done by an interventional radiologist with no periprocedural complications. Her subsequent hospital course was uncomplicated. A repeat arterial blood gas done one hour post procedure showed improvement in PO2 from 61 mm Hg to 85 mm Hg on room air. On subsequent follow-up visits she showed significant subjective improvement, maintainance of PO2 and correction of orthodeoxia. 
DISCUSSION
The incidence of PAVMs has been variably reported as 3.2 cases/year (Mayo Clinic, 1972)( 1 ) to 4.5 cases/year (Mayo clinic, 1981) ( 2 ). PAVMs occur twice as often in females as in males. Approximately 15%-35% patients with HHT have PAVMs ( 3 ). HHT, also called Osler-Weber-Rendu syndrome, is an autosomal dominant disorder, which presents with arterio venous malformations in skin, mucous membranes and visceral organs ( 4 ). Mutations in the gene for Endoglin ( 5 ) and activin receptor-like kinase1 are believed to cause HHT1 and HHT2 respectively ( 6 ). HHT families with endoglin mutations appear to have a higher incidence of PAVMs ( 7 ). 53%-70% of PAVMs occur in the lower lobes ( 8 ). Most patients are symptomatic between the fourth to sixth decades of life, however, in their early life, patients could present with severe cyanosis, congestive heart failure or respiratory failure ( 9 ). In patients with large or multiple PAVMs, dyspnea is found to be a very common symptom with finding of platypnea in some patients as well ( 9 ). Stroke or massive fatal hemoptysis could be the initial presentation of PAVMs ( 10 ). Not uncommonly they are associated with cerebrovacular accidents and brain abscesses with an incidence of aproximately10-15%( 9 , 11 ). Therefore, cryptogenic stroke in a young adult necessitates evaluation for the possibility of PAVMs in a previously undiagnosed patient ( 12 ).
Screening for HHT and PAVMs is recommended for all the family members of patients with HHT ( 9 ) and remains critical, as asymptomatic patients do not exclude clinically significant PAVMs and should have prophylactic antibiotics prior to dental and other surgical procedures to minimize risk of cerebral embolic abscesses. ( 9 , 11 , 13 ).
A practical approach would be to screen patients initially with chest radiograph ( 11 ), followed by Shunt measurement by 100% oxygen method. A PaO2 of > 90 mm Hg and a SO2 > 96.5% rule out any significant shunt, while a PaO2 < 85 mm Hg or a SO2 < 96% indicate a potential shunt fraction of > 5%. ( 9 ) Significant shunt fraction measurement of >5% necessitate workup by Contrast Echocardiography (sensitivity 92% with negative predictive value 97% ( 9 , 11 ). Further evaluation can be done by either pulmonary angiography or CT scan, prior to coil embolization or surgical resection ( 9 ).
All symptomatic PAVMs with a size greater than 2 cm and with feeding arteries greater than 3mm in diameter should be treated, either by surgery or embolotherapy ( 9 , 14 ) Transcatheter coil embolization (TCET) has become the treatment of choice replacing surgical intervention ( 11 , 14 ) and has shown significant reduction in right-to-left anatomic shunt fraction with a low complication rate ( 15 ). Better exercise capacity and improvement in hypoxemia has been shown in patients undergoing TCET ( 11 , 14 ) . Contrast echocardiography remains positive even after successful coil embolization treatment, ( 9 , 16 ), therefore, in patients undergoing TCET and post procedural persistence of right to left shunts with high risk of embolic events, surgery might be indicated ( 14 ) . Post procedure longitudinal monitoring of arterial blood gases in patients with HHT associated PAVMs is warranted to look for recurrence of PAVMs in these patients ( 17 ).
CONCLUSION
Embolotherapy for PAVMs avoids major surgery, general anesthesia and loss of lung parenchyma. It is the procedure of choice in patients with multiple or bilateral PAVMs and in patients who are poor surgical candidates. The benefits of embolotherapy are immediate and impressive with excellent long-term prognosis.
